Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks: An Open-Label Extension Study of the COMPACT Trial

Autor:	Jacques Hébert, William H. Yang, Clive Grattan, Constance H. Katelaris, Teresa Caballero, Iftikar Hussain, Donald Levy, Marco Cicardi, William R. Lumry, Avner Reshef, Dipti Pawaskar, Inmaculada Martinez-Saguer, Hilary Longhurst, Jonathan A. Bernstein, Michael R. Manning, Lawrence B. Schwartz, Henriette Farkas, Timothy J. Craig, Maria L. Baeza, Sergio Neri, Emel Aygören-Pürsün, Jana Hanzlikova, Gordon Sussman, Petra Staubach-Renz, John Anderson, Ioana Crisan, Iris Jacobs, Compact Investigators, Sandra C. Christiansen, Sarah Mycroft, Maria Dolores Hernandez, Markus Magerl, Marc A. Riedl, Henrike Feuersenger, Paul K. Keith, Konrad Bork, Henry Li, Bruce L. Zuraw, Joshua J. Jacobs, Shmuel Kivity, Ingo Pragst
Rok vydání:	2018
Předmět:	medicine.medical_specialty biology business.industry C1 Esterase Inhibitor Protein Extension study medicine.disease C1-inhibitor Internal medicine Hereditary angioedema biology.protein Long term outcomes Medicine Open label business
Zdroj:	SSRN Electronic Journal.
ISSN:	1556-5068
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b8f2a78528ba0ff476c84ac3b9d08bec https://doi.org/10.2139/ssrn.3247882 Zobrazit plný text záznamu